Silvana Libertini

1.5k total citations
31 papers, 1.1k citations indexed

About

Silvana Libertini is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Silvana Libertini has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Genetics. Recurrent topics in Silvana Libertini's work include Virus-based gene therapy research (10 papers), Cancer-related Molecular Pathways (8 papers) and CRISPR and Genetic Engineering (7 papers). Silvana Libertini is often cited by papers focused on Virus-based gene therapy research (10 papers), Cancer-related Molecular Pathways (8 papers) and CRISPR and Genetic Engineering (7 papers). Silvana Libertini collaborates with scholars based in United Kingdom, Italy and Switzerland. Silvana Libertini's co-authors include Giuseppe Portella, Paolo Chieffi, Spiros Linardopoulos, Giancarlo Troncone, Alfredo Fusco, David A. Gillespie, Donatella Tramontano, Ginevra Botta, Carmela Passaro and Mario Vitale and has published in prestigious journals such as Development, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Silvana Libertini

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvana Libertini United Kingdom 19 690 472 352 268 92 31 1.1k
Michael Tasch United States 6 950 1.4× 816 1.7× 203 0.6× 108 0.4× 157 1.7× 6 1.4k
Eric S. Hoffman United States 6 936 1.4× 864 1.8× 164 0.5× 118 0.4× 163 1.8× 6 1.6k
Mirentxu Santos Spain 20 855 1.2× 529 1.1× 180 0.5× 109 0.4× 197 2.1× 43 1.3k
Gaston Habets Netherlands 12 1.4k 2.0× 364 0.8× 482 1.4× 394 1.5× 117 1.3× 23 1.7k
Philippe Pujuguet Belgium 16 542 0.8× 446 0.9× 156 0.4× 71 0.3× 153 1.7× 22 1.1k
Serge Carillo France 17 975 1.4× 314 0.7× 295 0.8× 98 0.4× 137 1.5× 35 1.4k
Jesús V. Soriano United States 19 886 1.3× 494 1.0× 136 0.4× 194 0.7× 154 1.7× 25 1.3k
Scott Troutman United States 18 713 1.0× 285 0.6× 480 1.4× 60 0.2× 138 1.5× 25 1.3k
Franco Tatò Italy 19 1.0k 1.5× 254 0.5× 189 0.5× 275 1.0× 77 0.8× 33 1.3k
Etienne Danis United States 18 1.0k 1.5× 323 0.7× 209 0.6× 141 0.5× 232 2.5× 40 1.4k

Countries citing papers authored by Silvana Libertini

Since Specialization
Citations

This map shows the geographic impact of Silvana Libertini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Libertini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Libertini more than expected).

Fields of papers citing papers by Silvana Libertini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Libertini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Libertini. The network helps show where Silvana Libertini may publish in the future.

Co-authorship network of co-authors of Silvana Libertini

This figure shows the co-authorship network connecting the top 25 collaborators of Silvana Libertini. A scholar is included among the top collaborators of Silvana Libertini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvana Libertini. Silvana Libertini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sejersen, Thomas, Hildegard Büning, Michael Rothe, et al.. (2025). Pilocytic astrocytoma in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. 33(6). 2842–2850. 2 indexed citations
2.
Morath, Volker, Markus R. Anneser, Tarik Bozoglu, et al.. (2025). PET-based tracking of CAR T cells and viral gene transfer using a cell surface reporter that binds to lanthanide complexes. Nature Biomedical Engineering. 9(11). 1886–1906. 2 indexed citations
3.
Fischer, Benoit, Tara Alpert, Martin Beibel, et al.. (2025). SACF and GILA assays on AML12 cells show limited predictive value for mouse liver genotoxicity. Toxicology and Applied Pharmacology. 504. 117529–117529.
4.
Yasuda, Satoshi, Kiyoko Bando, Silvana Libertini, et al.. (2024). Detection of residual pluripotent stem cells in cell therapy products utilizing droplet digital PCR: an international multisite evaluation study. Stem Cells Translational Medicine. 13(10). 1001–1014. 3 indexed citations
5.
Tiwari, Nishant, Jennifer Vaughn, Saunder Bernes, et al.. (2023). Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. 31(10). 2991–2998. 18 indexed citations
6.
Perner, Juliane, Mathias Müller, Thierry Doll, et al.. (2022). Identification of marker genes to monitor residual iPSCs in iPSC-derived products. Cytotherapy. 25(1). 59–67. 14 indexed citations
7.
Fischer, Benoit, Lindsey Ulkus Rodrigues, Gráinne Kerr, et al.. (2021). Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells. Molecular Therapy — Methods & Clinical Development. 23. 241–253. 12 indexed citations
8.
Bando, Hideaki, Matteo Piazza, Genevíève Gowing, et al.. (2020). Safety of cell therapy products: in-vitro methods to assess the tumorigenicity of human cell-based therapeutic products. Cytotherapy. 22(5). S42–S42. 3 indexed citations
9.
Sato, Yoji, Hideaki Bando, Matteo Piazza, et al.. (2019). Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. Cytotherapy. 21(11). 1095–1111. 111 indexed citations
10.
Plappert‐Helbig, Ulla, Silvana Libertini, Wilfried Frieauff, Diethilde Theil, & Hans‐Jörg Martus. (2018). Gamma‐H2AX immunofluorescence for the detection of tissue‐specific genotoxicity in vivo. Environmental and Molecular Mutagenesis. 60(1). 4–16. 28 indexed citations
11.
Nolan, Karen A., S Santambrogio, Patrick Spielmann, et al.. (2018). Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype. Kidney International. 95(2). 375–387. 37 indexed citations
12.
Passaro, Carmela, Ginevra Botta, Eloise Scamardella, et al.. (2014). PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma. Molecular Oncology. 9(1). 78–92. 31 indexed citations
13.
Passaro, Carmela, Silvana Libertini, Ginevra Botta, et al.. (2013). Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells. Endocrine Related Cancer. 20(5). 633–647. 19 indexed citations
14.
Xu, Naihan, Silvana Libertini, Yaou Zhang, & David A. Gillespie. (2011). Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency. Biochemical and Biophysical Research Communications. 413(3). 465–470. 8 indexed citations
15.
Xu, Ning, Silvana Libertini, Elizabeth J. Black, et al.. (2011). Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage. Oncogene. 31(9). 1086–1094. 29 indexed citations
16.
Libertini, Silvana, Carmela Passaro, Ginevra Botta, et al.. (2010). AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947. Endocrine Related Cancer. 18(1). 129–141. 37 indexed citations
17.
Botta, Ginevra, Giuseppe Perruolo, Silvana Libertini, et al.. (2010). PED/PEA-15 Modulates Coxsackievirus–Adenovirus Receptor Expression and Adenoviral Infectivity via ERK-Mediated Signals in Glioma Cells. Human Gene Therapy. 21(9). 1067–1076. 16 indexed citations
18.
Esposito, Francesco, et al.. (2009). Expression of Concern: Aurora B expression in post‐puberal testicular germ cell tumours. Journal of Cellular Physiology. 221(2). 435–439. 40 indexed citations
19.
Formisano, Pietro, Giuseppe Perruolo, Silvana Libertini, et al.. (2005). Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. Oncogene. 24(47). 7012–7021. 32 indexed citations
20.
Portella, Giuseppe, Roberto Pacelli, Silvana Libertini, et al.. (2003). ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells. The Journal of Clinical Endocrinology & Metabolism. 88(10). 5027–5032. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Tasch Breakdown of academic impact, for papers by Eric S. Hoffman Breakdown of academic impact, for papers by Mirentxu Santos Breakdown of academic impact, for papers by Gaston Habets Breakdown of academic impact, for papers by Philippe Pujuguet Breakdown of academic impact, for papers by Serge Carillo Breakdown of academic impact, for papers by Jesús V. Soriano Breakdown of academic impact, for papers by Scott Troutman Breakdown of academic impact, for papers by Franco Tatò Breakdown of academic impact, for papers by Etienne Danis
Rankless by CCL
2026